A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 171, Issue 3, 2016, Pages 414-426

  Yin, Honglei ^a,b,c   Pantazatos, Spiro P ^b   Galfalvy, Hanga ^b   Huang, Yung yu ^b,c   Rosoklija, Gorazd B ^b,c   Dwork, Andrew J ^b   Burke, Ainsley ^b   Arango, Victoria ^b,c   Oquendo, Maria A ^b,c   Mann, Joseph John ^b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

GABA; Gene expression; Glutamate; Major depressive disorder; Suicidal behavior

Indexed keywords

4 AMINOBUTYRIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; GLUTAMIC ACID;

ADULT; ARTICLE; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; GABAERGIC TRANSMISSION; GENETIC ASSOCIATION; GLUTAMATERGIC SYNAPSE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RNA SEQUENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN DEATH; SUICIDAL BEHAVIOR; SUICIDE; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; GENOTYPE; METABOLISM; MIDDLE AGED; PILOT STUDY; POSTMORTEM CHANGE; PROCEDURES; SUICIDAL IDEATION;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; GENOMICS; GENOTYPE; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMORTEM CHANGES; SUICIDAL IDEATION;

EID: 84975763818     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32423     Document Type: Article

References (68)

1. Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, Schatzberg AF, Myers RM, Akil H, Watson SJ. 2011. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 16:634-646.
2. Borges G, Nock MK, Haro Abad JM, Hwang I, Sampson NA, Alonso J, Andrade LH, Angermeyer MC, Beautrais A, Bromet E, Bruffaerts R, de Girolamo G, Florescu S, Gureje O, Hu C, Karam EG, Kovess-Masfety V, Lee S, Levinson D, Medina-Mora ME, Ormel J, Posada-Villa J, Sagar R, Tomov T, Uda H, Williams DR, Kessler RC. 2010. Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. J Clin Psychiatry 71:1617-1628.
3. Brambilla P, Perez J, Barale F, Schettini G, Soares JC. 2003. GABAergic dysfunction in mood disorders. Mol Psychiatry 8:721-737, 715.
4. Briere FN, Rohde P, Seeley JR, Klein D, Lewinsohn PM. 2014. Comorbidity between major depression and alcohol use disorder from adolescence to adulthood. Compr Psychiatry 55:526-533.
5. Chandley MJ, Szebeni K, Szebeni A, Crawford J, Stockmeier CA, Turecki G, Miguel-Hidalgo JJ, Ordway GA. 2013. Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. J Psychiatry Neurosci 38:276-284.
6. Chiesa A, Crisafulli C, Porcelli S, Han C, Patkar AA, Lee SJ, Park MH, Jun TY, Serretti A, Pae CU. 2012. Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder. Eur Arch Psychiatry Clin Neurosci 262:305-311.
7. Chiesa A, Lia L, Lia C, Lee SJ, Han C, Patkar AA, Pae CU, Serretti A. 2013. Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder. J Int Med Res 41:809-815.
8. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE, Jr, Akil H, Watson SJ, Jones EG. 2005. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 102:15653-15658.
9. Domart MC, Benyamina A, Lemoine A, Bourgain C, Blecha L, Debuire B, Reynaud M, Saffroy FR. 2012. Association between a polymorphism in the promoter of a glutamate receptor subunit gene (GRIN2A) and alcoholism. Addict Biol 17:783-785.
10. Fatemi SH, Folsom TD, Rooney RJ, Thuras PD. 2013. Expression of GABAA alpha2-, beta1- and epsilon-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression, and bipolar disorder. Transl Psychiatry 3:e303.
11. Feng Y, Kapornai K, Kiss E, Tamas Z, Mayer L, Baji I, Daroczi G, Benak I, Kothencne VO, Dombovari E, Kaczvinszk E, Besnyo M, Gadoros J, Szekely J, Kovacs M, Vetro A, Kennedy JL, Barr CL. 2010. Association of the GABRD gene and childhood-onset mood disorders. Genes Brain Behav 9:668-672.
12. Fiori LM, Turecki G. 2010. Gene expression profiling of suicide completers. Eur Psychiatry 25:287-290.
13. Fonnum F. 1984. Glutamate: A neurotransmitter in mammalian brain. J Neurochem 42:1-11.
14. Galfalvy H, Haghighi F, Hodgkinson C, Goldman D, Oquendo MA, Burke A, Huang YY, Giegling I, Rujescu D, Bureau A, Turecki G, Mann JJ. 2015. A genome-wide association study of suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 168:557-563
15. Gelenberg AJ. 2010. The prevalence and impact of depression. J Clin Psychiatry 71:e06.
16. Haghighi F, Xin Y, Chanrion B, O'Donnell AH, GE Y, Dwork AJ, Arango V, Mann JJ. 2014. Increased DNA methylation in the suicide brain. Dialogues Clin Neurosci 16:430-438.
17. Hirschfeld RM. 2012. The epidemiology of depression and the evolution of treatment. J Clin Psychiatry 73(Suppl 1):5-9.
18. Huang YY, Grailhe R, Arango V, Hen R, Mann JJ. 1999. Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology 21:238-246.
19. Ittiwut C, Yang BZ, Kranzler HR, Anton RF, Hirunsatit R, Weiss RD, Covault J, Farrer LA, Gelernter J. 2012. GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. Alcohol Clin Exp Res 36:588-593.
20. Kelly TM, Mann JJ. 1996. Validity of DSM-III-R diagnosis by psychological autopsy: A comparison with clinician ante-mortem diagnosis. Acta Psychiatr Scand 94:337-343.
21. Kertes DA, Kalsi G, Prescott CA, Kuo PH, Patterson DG, Walsh D, Kendler KS, Riley BP. 2011. Neurotransmitter and neuromodulator genes associated with a history of depressive symptoms in individuals with alcohol dependence. Alcohol Clin Exp Res 35:496-505.
22. Kim S, Choi KH, Baykiz AF, Gershenfeld HK. 2007. Suicide candidate genes associated with bipolar disorder and schizophrenia: An exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 8:413.
23. Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, Ffrench-Mullen J, Turecki G. 2009. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry 14:175-189.
24. Labonte B, Suderman M, Maussion G, Lopez JP, Navarro-Sanchez L, Yerko V, Mechawar N, Szyf M, Meaney MJ, Turecki G. 2013. Genome-wide methylation changes in the brains of suicide completers. Am J Psychiatry 170:511-520.
25. Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, Winiger E, Bhosrekar S, Shankar G, Radel M, Bellanger E, Duckworth H, Olesek K, Vergo J, Schweitzer R, Yard M, Ballew A, Shekhar A, Sandusky GE, Schork NJ, Kurian SM, Salomon DR, Niculescu AB, III. 2013. Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry 18:1249-1264.
26. Levinson AJ, Fitzgerald PB, Favalli G, Blumberger DM, Daigle M, Daskalakis ZJ. 2010. Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 67:458-464.
27. Mandelli L, Serretti A. 2013. Gene environment interaction studies in depression and suicidal behavior: An update. Neurosci Biobehav Rev 37:2375-2397.
28. Mann JJ, Oquendo MA, Watson KT, Boldrini M, Malone KM, Ellis SP, Sullivan G, Cooper TB, Xie S, Currier D. 2014. Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid. Depress Anxiety 31:814-821.
29. Medina A, Burke S, Thompson RC, Bunney W, Jr, Myers RM, Schatzberg A, Akil H, Watson SJ. 2013. Glutamate transporters: A key piece in the glutamate puzzle of major depressive disorder. J Psychiatr Res 47:1150-1156.
30. Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H. 2004. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 24:1478-1485.
31. Miguel-Hidalgo JJ, Waltzer R, Whittom AA, Austin MC, Rajkowska G, Stockmeier CA. 2010. Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. J Affect Disord 127:230-240.
32. Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, et al. 2015. A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder. Mol. Psychiatry doi: 10.1038/mp.2015.83 [Epub ahead of print].
33. Mohler H. 2012. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62:42-53.
34. Murphy TM, Ryan M, Foster T, Kelly C, McClelland R, O'Grady J, Corcoran E, Brady J, Reilly M, Jeffers A, Brown K, Maher A, Bannan N, Casement A, Lynch D, Bolger S, Tewari P, Buckley A, Quinlivan L, Daly L, Kelleher C, Malone KM. 2011. Risk and protective genetic variants in suicidal behaviour: Association with SLC1A2, SLC1A3, 5-HTR1B & NTRK2 polymorphisms. Behav Brain Funct 7:22.
35. Myung W, Song J, Lim SW, Won HH, Kim S, Lee Y, Kang HS, Lee H, Kim JW, Carroll BJ, Kim DK. 2012. Genetic association study of individual symptoms in depression. Psychiatry Res 198:400-406.
36. NCIPC. 2013. http://www.cdc.gov/violenceprevention/pdf/suicide-datasheet-a.pdf
37. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ. 2010. Trait-associated SNPs are more likely to be eQTLs: Annotation to enhance discovery from GWAS. PLoS Genet 6:e1000888.
38. Nilsen TW, Graveley BR. 2010. Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457-463.
39. Oh DH, Oh D, Son H, Webster MJ, Weickert CS, Kim SH. 2014. An association between the reduced levels of SLC1A2 and GAD1 in the dorsolateral prefrontal cortex in major depressive disorder: Possible involvement of an attenuated RAF/MEK/ERK signaling pathway. J Neural Transm 121:783-792.
40. Oquendo MA, Friend JM, Halberstam B, Brodsky BS, Burke AK, Grunebaum MF, Malone KM, Mann JJ. 2003. Association of comorbid posttraumatic stress disorder and major depression with greater risk for suicidal behavior. Am J Psychiatry 160:580-582.
41. Owen RT. 2012. Glutamatergic approaches in major depressive disorder: Focus on ketamine, memantine, and riluzole. Drugs Today (Barc) 48:469-478.
42. Pantazatos SP, Andrews SJ, Dunning-Broadbent J, Pang J, Huang YY, Arango V, Nagy PL, John Mann J. 2015. Isoform-level brain expression profiling of the spermidine/spermine N1-Acetyltransferase1 (SAT1) gene in major depression and suicide. Neurobiol Dis 79:123-134.
43. Petty F. 1995. GABA and mood disorders: A brief review and hypothesis. J Affect Disord 34:275-281.
44. Posner K, Oquendo MA, Gould M, Stanley B, Davies M. 2007. Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 164:1035-1043.
45. Pu M, Zhang Z, Xu Z, Shi Y, Geng L, Yuan Y, Zhang X, Reynolds GP. 2013. Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response. Pharmacogenomics 14:277-288.
46. Rajkowska G, Miguel-Hidalgo JJ. 2007. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6:219-233.
47. Sanacora G, Saricicek A. 2007. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS Neurol Disord Drug Targets 6:127-140.
48. Sapolsky RM. 2000. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925-935.
49. Schweizer C, Balsiger S, Bluethmann H, Mansuy IM, Fritschy JM, Mohler H, Luscher B. 2003. The gamma 2 subunit of GABA(A) receptors is required for maintenance of receptors at mature synapses. Mol Cell Neurosci 24:442-450.
50. Sequeira A, Klempan T, Canetti L, Ffrench-Mullen J, Benkelfat C, Rouleau GA, Turecki G. 2007. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 12:640-655.
51. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, Rehal S, Klempan T, Gratton A, Benkelfat C, Rouleau GA, Mechawar N, Turecki G. 2009. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 4:e6585.
52. Shoval G, Shmulewitz D, Wall MM, Aharonovich E, Spivak B, Weizman A, Hasin D. 2014. Alcohol dependence and suicide-related ideation/behaviors in an Israeli household sample, with and without major depression. Alcohol Clin Exp Res 38:820-825.
53. Sibille E, Arango V, Galfalvy HC, Pavlidis P, Erraji-Benchekroun L, Ellis SP, John Mann J. 2004. Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 29:351-361.
54. Sokolowski M, Ben-efraim YJ, Wasserman J, Wasserman D. 2013. Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: Associations and gene-environment interactions with childhood/adolescent physical assault. Mol Psychiatry 18:985-992.
55. Spitzer RL, Williams JB, Gibbon M, First MB. 1992. The structured clinical interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49:624-629.
56. Stewart CA, Reid IC. 2002. Antidepressant mechanisms: Functional and molecular correlates of excitatory amino acid neurotransmission. Mol Psychiatry 7(Suppl 1):S15-S22.
57. Tao R, Li C, Newburn EN, Ye T, Lipska BK, Herman MM, Weinberger DR, Kleinman JE, Hyde TM. 2012. Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders. J Neurosci 32:5216-5222.
58. Terranova C, Tucci M, Sartore D, Cavarzeran F, Di Pietra L, Barzon L, Palu G, Ferrara SD. 2013. GABA receptors, alcohol dependence, and criminal behavior. J Forensic Sci 58:1227-1232.
59. Trabzuni D, Ryten M, Walker R, Smith C, Imran S, Ramasamy A, Weale ME, Hardy J. 2011. Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J Neurochem 119:275-282.
60. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L. 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7:562-578.
61. Tripp A, Oh H, Guilloux JP, Martinowich K, Lewis DA, Sibille E. 2012. Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry 169:1194-1202.
62. Unschuld PG, Ising M, Specht M, Erhardt A, Ripke S, Heck A, Kloiber S, Straub V, Brueckl T, Muller-Myhsok B, Holsboer F, Binder EB. 2009. Polymorphisms in the GAD2 gene-region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 150B:1100-1109.
63. van Heeringen C, Bijttebier S, Godfrin K. 2011. Suicidal brains: A review of functional and structural brain studies in association with suicidal behaviour. Neurosci Biobehav Rev 35:688-698.
64. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476.
65. World Health Organization. 2014. http://www.who.int/mediacentre/factsheets/fs398/en
66. Zai CC, Zai GC, Tiwari AK, Manchia M, de Luca V, Shaikh SA, Strauss J, Kennedy JL. 2014. Association study of GABRG2 polymorphisms with suicidal behaviour in schizophrenia patients with alcohol use disorder. Neuropsychobiology 69:154-158.
67. Zarate CA, Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. 2006. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864.
68. Zhou Y, Danbolt NC. 2013. GABA and glutamate transporters in brain. Front Endocrinol (Lausanne) 4:165.